Scilex Holding (SCLX) Preferred Shares (2022 - 2025)
Scilex Holding (SCLX) posted quarterly Preferred Shares of $1000.0 for Q4 2025, little changed quarter-over-quarter from $1000.0 in Q3 2025.
Scilex Holding (SCLX) Preferred Shares (2022 - 2025) Analysis & Trends
Scilex Holding's Preferred Shares history runs 3 years deep, the most recent figure standing at $1000.0 for Q4 2025.
- In Q4 2025, Preferred Shares changed N/A year-over-year to $1000.0; the TTM figure through Dec 2025 stood at $1000.0 (changed N/A YoY), while the FY2025 annual figure was $1000.0, changed N/A from the prior year.
- Preferred Shares for Q4 2025 stood at $1000.0, roughly flat from $1000.0 in the prior quarter.
- The five-year high for Preferred Shares was $3000.0 in Q4 2022, with the low at $1000.0 in Q1 2025.
- The 3-year median for Preferred Shares is $2000.0 (2022), against an average of $2000.0.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.45 Bn | 631.70 Bn | 17.26 Bn | - |
| 2 | AbbVie | 469.14 Bn | 462.57 Bn | 12.70 Bn | - |
| 3 | Merck | 381.04 Bn | 373.90 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 301.58 Bn | 293.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.69 Bn | 252.79 Bn | 12.86 Bn | - |
| 6 | Amgen | 236.91 Bn | 222.92 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.62 Bn | 179.44 Bn | 6.22 Bn | - |
| 8 | Pfizer | 161.28 Bn | 149.58 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.81 Bn | 101.64 Bn | 8.24 Bn | - |
| 10 | Scilex Holding | 39.97 Mn | -72.82 Mn | 3.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |